Voyager Therapeutics Stock Price (NASDAQ:VYGR)

Add to My Stocks
$18.02 $0.37 (2.01%) VYGR stock closing price Sep 19, 2018 (Closing)
Prev Close* : $18.39
Market Cap:
$596.5M
Day Low: $17.69
52 Week Low: $11.54
Open: $18.1
Volume: -
Day High: $18.6
52 Week High: $31.91
Dividend:
0.00

Latest Stock Market News

Latest Articles

Voyager Therapeutics News - From Partners

VYGR Stockcharts

View VYGR PE ratio, PS ratio stocks charts and compare with peers.
VYGR Chart
Note: Compare Voyager Therapeutics stock price history with the index and industry peers.

Voyager Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
52.29
PB ratio (
price to book ratio
)
5.71

Voyager Therapeutics Returns

ROE
(return on equity)
-80%

Voyager Therapeutics Financial Ratios

Asset Turnover
0.05
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
0%

VYGR Industry Peers

Company Price Change (%)
Cymabay (CBAY)12.090.71 (5.55%)
Skyepharma (SKYEY)6.280.02 (0.32%)
Ionis Pharma (IONS)49.980.62 (1.26%)
Ptc Therapeutics (PTCT)45.371.82 (3.86%)
Biogen Inc (BIIB)338.912.02 (0.6%)
Spark Therapeutics (ONCE)56.631.43 (2.46%)
Neuroderm (NDRM)38.850 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)6.420.42 (7%)
Supernus Pharma (SUPN)47.91 (2.13%)
Mylan (MYL)38.240.43 (1.14%)
BAUSCH HEALTH (BHC)24.070.26 (1.09%)
Allergan (AGN)188.031.96 (1.05%)
Dr. Reddy's Laboratories (RDY)36.20.35 (0.98%)
Teligent (TLGT)3.780.03 (0.8%)
Top gainers from Medical-Generic Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
Mallinckrodt (MNK)29.680.11 (0.37%)
Corium (CORI)8.920.01 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Sep 20, 2018

Voyager Therapeutics Inc Stock News - Partner Headlines

Voyager Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues10.13M14.22M17.33M--
Net Income-70.69M-40.19M-29.67M-16.31M-3.83M
Total Operating Expense81.99M55.51M37.57M14.35M3.76M
View Voyager Therapeutics income statement
balance sheet20172016201520142013
Total Assets184.47M189.56M229.45M11.49M-
Total Liabilities50.42M53.64M60.38M10.34M3.98M
Shareholders Equity134.05M135.92M169.07M1.14M-3.83M
View Voyager Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.62M-11.79M56.41M1.24M1.04M
Net Cash from (used by) Operating Activities-61.35M-42.48M41.29M-11.91M-2.72M
Increase (Decrease) in Prop Plant And Equipment-3.98M-5.02M-1.03M-2.98M-
View Voyager Therapeutics cash flow statement

Voyager Therapeutics Stock Message Board

An investor needs to spend $18.02 to buy VYGR stock, as the closing Voyager Therapeutics stock price is $18.02. Stock price or share price can be used to find the total market value of a company. Voyager Therapeutics market cap stands at $596.5M as of Sep 19, 2018. A value investor must look at the fundamentals of a stock, and perform Voyager Therapeutics valuation, even though in the short-term, sentiment and current breaking news might affect Voyager Therapeutics stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy VYGR stock than sell it, then Voyager Therapeutics stock price goes up. Conversely, if more investors wanted to sell VYGR stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Voyager Therapeutics stock quote data shows the number of shares traded. For Ex: 294,856 Voyager Therapeutics shares were traded as of last trading day, as seen from Voyager Therapeutics stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Voyager Therapeutics stock dividend was 0.00 during the last quarter. Voyager Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.